Podoplanin, which is immunoreactive to D2-40 antibody, is reportedly expressed in lymphatic vessels in non-neoplastic tissues, and also in vascular and non-vascular tumors. However, its expression in ...
Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies Oral ...
Scientists headed by a team at the University of Tokyo have identified a protein, known as podoplanin (PDPN), that is common to both human and canine mucosal melanoma, and which appears to mobilize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results